Business

Announcement on Voluntary Disclosure of Obtaining FDA Approval for the Clinical Trial of ZG005 for Injection In Combination with ZGGS18 for Injection

Announcement on Voluntary Disclosure of Obtaining FDA Approval for the Clinical Trial of ZG005 for Injection In Combination with ZGGS18 for Injection

articleSuzhou Zelgen Biopharmaceuticals Co. Ltd. Class AAugust 29, 20255/news/announcement-on-voluntary-disclosure-of-obtaining-fda-approval-for-the-clinical-trial-of-zg005-for-injection-in-combination-with-zggs18-for-injection
Announcement on Voluntary Disclosure of Obtaining FDA Approval for the Clinical Trial of ZG005 for Injection In Combination with ZGGS18 for Injection

About this update from Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A

Announcement on Voluntary Disclosure of Obtaining FDA Approval for the Clinical Trial of ZG005 for Injection In Combination with ZGGS18 for InjectionThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A